Skip to main content
main-content

Zeitschrift

Clinical and Translational Oncology

Clinical and Translational Oncology 1/2015

Ausgabe 1/2015

Inhaltsverzeichnis ( 11 Artikel )

01.01.2015 | Educational Series – Blue Series | Ausgabe 1/2015

Translation in solid cancer: are size‐based response criteria an anachronism?

M. Fernandes, D. Rosel, J. Brábek

01.01.2015 | Educational Series – Red Series | Ausgabe 1/2015

Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology

J. de Castro, M. Cobo, D. Isla, J. Puente, N. Reguart, B. Cabeza, A. Gayete, M. Sánchez, M. I. Torres, J. Ferreirós

01.01.2015 | Research Article | Ausgabe 1/2015

Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain

G. Villa, L. J. Hernández-Pastor, M. Guix, J. Lavernia, M. Cuesta

01.01.2015 | Brief Research Article | Ausgabe 1/2015

MiR-215/192 participates in gastric cancer progression

Y. J. Xu, Y. Fan

01.01.2015 | Research Article | Ausgabe 1/2015

EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma

Z. Q. Xu, L. Zhang, B. S. Gao, Y. G. Wan, X. H. Zhang, B. Chen, Y. T. Wang, N. Sun, Y. W. Fu

01.01.2015 | Research Article | Ausgabe 1/2015

Interleukin-17 is a favorable prognostic marker for colorectal cancer

Y. Lin, J. Xu, H. Su, W. Zhong, Y. Yuan, Z. Yu, Y. Fang, H. Zhou, C. Li, K. Huang

01.01.2015 | Research Article | Ausgabe 1/2015

Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy

L.-P. Ge, J. Li, Q.-L. Bao, P. Chen, Q. Jiang, L.-R. Zhu

01.01.2015 | Research Article | Ausgabe 1/2015

Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53

Z.-G. Shi, S.-Q. Li, Z.-J. Li, X.-J. Zhu, P. Xu, G. Liu

01.01.2015 | Research Article | Ausgabe 1/2015

A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products

A. Estévez-Braun, A. G. Ravelo, E. Pérez-Sacau, J. C. Lacal

01.01.2015 | Correspondence | Ausgabe 1/2015

Indirect comparisons in cost-effectiveness analysis: are we being naïve?

J. Martin-Broto

01.01.2015 | Acknowledgement to Referees | Ausgabe 1/2015

Acknowledgement to Referees 2014

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise